Mortality by hypertensive heart disease in Brazilian macroregions
DOI:
https://doi.org/10.15448/1983-652X.2017.2.24456Keywords:
hypertensive heart disease, hypertension, epidemiology.Abstract
Introduction: Cardiovascular diseases are in first place among the causes of death in Brazil. Hypertensive heart disease (HHD) describes a target-organ response spectrum, which includes coronary artery disease, left ventricular hypertrophy, heart failure and arrhythmias.Objective: To carry out an epidemiological analysis of mortality by HHD in the Brazilian regions. Materials and Methods: Descriptive population-based study of mortality rates with secondary data, as well as comparative analysis between the Brazilian regions using the following variables: gender, age group, year of death, color/race and education.
Results: There was a large increase in crude mortality rates from 40 to 59 years. HHD occurred mainly in brown people in the North, Northeast and Midwest, and whites in the South and Southeast regions, probably due to greater predominance of these phenotypes in their respective areas. Regarding sex, mortality was high in both. The number of deaths is inversely proportional to the number of years of schooling in all regions, with the highest values in the illiterate group.
Conclusion: We have observed that, as age increases, there is an elevated mortality rate, especially where there is a greater insecurity in health care, control, follow-up and preventive measures, as well as in mechanisms of funding transfer, such as in the Northeast.
References
Godoy MF, Lucena JM, Miquelin AR, Paiva FF, Oliveira DL, Augustin Junior JL, Chiaravalloti Neto F. Cardiovascular mortality and its relation to socioeconomic levels among inhabitants of Sao Jose do Rio Preto, Sao Paulo state, Brazil. Arq Bras Cardiol. 2007;88(2): 200-6. https://doi.org 10.1590/S0066-782X2007000200011
Malachias MVB, Souza WKSB, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT, Bortolotto LA, Franco RJS, Poli-de-Figueiredo CE, Jardim PCBV, Amodeo C, Barbosa ECD, Koch V, Gomes MAM, Paula RB, Póvoa RMS, Colombo FC, Ferreira Filho S, Miranda RD, Machado CA, Nobre F, Nogueira AR, Mion Júnior D, Kaiser S, Forjaz CLM, Almeida FA, Martim JFV, Sass N, Drager LF, Muxfeldt E, Bodanese LC, Feitosa AD, Malta D, Fuchs S, agalhães ME, Oigman W, Moreira Filho O, Pierin AMG, Feitosa GS, Bortolotto MRFL, Magalhães LBNC, Silva ACS, Ribeiro JM, Borelli FAO, Gus M, Passarelli Júnior O, Toledo JY, Salles GF, Martins LC, Jardim TSV, Guimarães ICB, Antonello IC, Lima Júnior E, Matsudo V, Silva GV, Costa LS, Alessi A, Scala LCN, Coelho EB, Souza D, Lopes HF, Gowdak MMG, Cordeiro Júnior AC, Torloni MR, Klein MRST, Nogueira PK, Lotaif LAD, Rosito GBA, Moreno Júnior H. 7ª Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107 (3 Supl 3):1-83. https://doi.org/10.5935/abc.20160140
Lessa I. Epidemiologia da hipertensão arterial sistêmica e da insuficiência cardíaca no Brasil. Rev Bras Hipertens. 2001;8:383-92.
Sant'Anna MP, Mello RJVd, Montenegro LT, Araújo MM. Left and right ventricular hypertrophy at autopsy of hypertensive individuals. Rev Assoc Med Bras. 2012;58(1):41-7. https://doi.org/10.1016/ S0104-4230(12)70153-7
McMaster, WG. Kirabo, A. Madhur, MS, Harrison, DG. Inflammation, Immunity, and Hypertensive End-Organ Damage. Circ Res. 2015;116(6):1022-33. https://doi.org/10.1161/CIRCRESAHA.116. 303697
Acharya T, Tringali S, Singh M, Huang J. Resistant hypertension and associated comorbidities in a veterans affairs population. J Clin Hypertens (Greenwich). 2014 Oct;16(10):741-5. https://doi.org/10.1111/jch.12410
Nogueira PR, Rassi S, Corrêa KdS. Epidemiological, clinical e therapeutic profile of heart failure in a tertiary hospital. Arq Bras Cardiol. 2010;95(3):392-8. https://doi.org/10.1590/S0066-782X2010005000102
Bocchi EA, Marcondez-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues D, Mesquita ET, Vilas-Boas F, Cruz F, Ramirez F, Villacorta Junior H, Souza Neto JD, Rossi Neto JM, Moura LZ, Beck-da-Silva L, Moreira LF, Rohde LEP, Montera MW, Simões MV, Moreira MC, Clausell N, Bestetti R, Mourilhe-Rocha R, Mangini S, Rassi S, Ayub-Ferreira SM, Martins SM, Bordignon S, Issa VS. Sociedade Brasileira de Cardiologia. Atualização da Diretriz Brasileira de Insuficiência Cardíacacrônica - 2012. Arq Bras Cardiol. 2012;98(1 Supl. 1):1-33. https://doi.org/10.1590 /S0066-782X2012001000001
Raman SV. The Hypertensive heart: an integrated understanding informed by imaging. J Am Coll Cardiol. 2010;55(2):91-6. https://doi.org/10.1016 j.jacc.2009. 07.059
Bombig MTN, Povoa R. Cardiopatia hipertensiva: aspectos epidemiológicos, prevalência e fator de risco cardiovascular. Rev Bras Hipertens. 2008;15(2):75-80.
Hoey ETD, Pakala V, Teoh JK, Simpson H. The Role of Imaging in Hypertensive Heart Disease. Int J Angiol. 2014 Jun;23(2):85-92. https://doi.org/10.1055/s-0034-1370885
Lai YH, Lo CI, Wu YJ, Hung CL, Yeh HI. Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart Diseases. Zhonghua Minguo Xin Zang Xue Hui Za Zhi. 2013 Jan;29(1):64-70.
Schmidt A. Insuficiência cardíaca diastólica e sistólica em pacientes hipertensos: diagnóstico e tratamento diferenciais Revista Brasileira de Hipertansão. Rev Bras Hipertens. 2001;8:440-44.
Schmidt MI, Duncan BB, Hoffmann JF, Moura Ld, Malta DC, Carvalho RMSVd. Prevalence of diabetes and hypertension based on self-reported morbidity survey, Brazil, 2006. Rev Saúde Públ. 2009;43:74-82. https://doi.org/10.1590/S0034-89102009000900010
Simöes CCdS. Perfis de saúde e de mortalidade no Brasil: uma análise de seus condicionantes em grupos populacionais específicos. Brasília: OPAS; 2002.
Antoniucci D, Seccareccia F, Menotti A, Dovellini EV, Prati PL, Rovelli F, Fazzini PF. Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. G Ital Cardiol. 1997;27(4): 363-9.
Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484-95. https://doi.
org/10.1161/CIRCULATIONAHA.113.007094
Song K, Wang S, Huang B, Luciano A, Srivastava R, Mani A. Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: a meta-analysis. J Clin Hypertens (Greenwich). 2014;16(9):686-92. https://doi.org/10.1111/jch.12376
Todoran TM, Zile MR. Neuromodulation device therapy for treatment of hypertensive heart disease. Circ J. 2013;77(6): 1351-63. https://doi.org /10.1253/circj.CJ-13-0390
Downloads
Published
Issue
Section
License
COPYRIGHT
The submission of originals to Ciência & Saúde implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Ciência & Saúde as the site of original publication.
CREATIVE COMMONS LICENSE
As this journal is open access, the articles are allowed free use in scientific and educational applications, with citation of the source.
According to the type of Creative Commons License (CC-BY 4.0) adopted by Ciência & Saúde , the user must respect the requirements below.
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
However, only under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests Ciência & Saúde endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
For more details on the Creative Commons license, please follow the link in the footer of this website.
